Besides, two of the 12 (16.7%) PALB2 carriers were diagnosed with mixed invasive micropapillary carcinoma, an aggressive type of breast cancer with an unfavorable clinical prognosis (Middleton et al. 1999). This evidence concerns the gene PALB2 and breast cancer.